
CAS 2265899-49-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
1 produits concernés.
ORN0829
CAS :<p>ORN0829 is a novel, orally active, potent, and selective antagonist of serotonin 5-HT2A receptors. ORN0829 has been shown to inhibit the growth of human cancer cells in vitro and in vivo with a side-effect profile that is significantly less than other 5-HT2A antagonists currently in clinical development. ORN0829 also inhibits the binding of serotonin to 5-HT2A receptors and blocks the downstream signaling pathways of phospholipase C, protein kinase C, and mitogen-activated protein kinases.<br>ORN0829 has an onset latency time of about 1 hour and its pharmacokinetic properties have been evaluated in both mice and rats. In these studies, ORN0829 was found to be well tolerated with no observed adverse effects.</p>Formule :C23H22FN7O2Degré de pureté :Min. 95%Masse moléculaire :447.47 g/mol
